Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Yuxi Liu, Jingwen Li, Junying Li, Han Yan, Bing Qiao, Yadan Wang, Yu Hu & Chunyan Sun. (2023) The predictive value of MiR-221 in cancer chemoresistance: a systematic review and meta-analysis. Expert Review of Anticancer Therapy 23:8, pages 883-895.
Read now
Read now
Rong Zhang & Cai-hong Huo. (2020) Long Noncoding RNA SOCS2-AS Promotes Leukemogenesis in FLT3-ITD+ Acute Myeloid Leukemia Through miRNA-221. OncoTargets and Therapy 13, pages 2925-2934.
Read now
Read now
Pengliang Xin, Wenqian Xu, Xiongpeng Zhu, Chuntuan Li, Yan Zheng, Tingjin Zheng, Wenzhao Cheng & Qunyi Peng. (2019) Protective autophagy or autophagic death: effects of BEZ235 on chronic myelogenous leukemia. Cancer Management and Research 11, pages 7933-7951.
Read now
Read now
Articles from other publishers (23)
Atefe Rahmati, Alireza Mafi, Omid Vakili, Firooze Soleymani, Zahra Alishahi, Sheida Yahyazadeh, Yasaman Gholinezhad, Malihe Rezaee, Thomas P. Johnston & Amirhossein Sahebkar. (2023) Non-coding RNAs in leukemia drug resistance: new perspectives on molecular mechanisms and signaling pathways. Annals of Hematology.
Crossref
Crossref
Bedanta Bhattacharjee, Ayesha Farhana Syeda, Damanbhalang Rynjah, Shalam M. Hussain, Shekhar Chandra Bora, Padmanath Pegu, Ram Kumar Sahu & Jiyauddin Khan. (2023) Pharmacological impact of microRNAs in head and neck squamous cell carcinoma: Prevailing insights on molecular pathways, diagnosis, and nanomedicine treatment. Frontiers in Pharmacology 14.
Crossref
Crossref
Faizah Alotaibi. (2023) Exosomal microRNAs in cancer: Potential biomarkers and immunotherapeutic targets for immune checkpoint molecules. Frontiers in Genetics 14.
Crossref
Crossref
Dan Ma, Ping Liu, Chujiao Hu, Zhen Zhou, Ping Wang, Yan Wang, Yaming Zhang, Yunsheng Ran, Pinghao Li, Jiangyuan Zhao, Jishi Wang, Chengliang Zhang & Lei Tang. (2022) Intracellular angiopoietin-1 promotes TKI-resistance via activation of JAK/STAT5 pathway in chronic myeloid leukemia. Oncogene 42:2, pages 124-137.
Crossref
Crossref
Mohammad H. Ghazimoradi, Naeim Karimpour-Fard & Sadegh Babashah. (2023) The Promising Role of Non-Coding RNAs as Biomarkers and Therapeutic Targets for Leukemia. Genes 14:1, pages 131.
Crossref
Crossref
Priyanka Singh, Radheshyam Yadav, Malkhey Verma & Ravindresh Chhabra. (2022) Antileukemic Activity of hsa-miR-203a-5p by Limiting Glutathione Metabolism in Imatinib-Resistant K562 Cells. Current Issues in Molecular Biology 44:12, pages 6428-6438.
Crossref
Crossref
Alexander Rudich, Ramiro Garzon & Adrienne Dorrance. (2022) Non-Coding RNAs Are Implicit in Chronic Myeloid Leukemia Therapy Resistance. International Journal of Molecular Sciences 23:20, pages 12271.
Crossref
Crossref
Sara Peixoto da Silva, Hugo R. Caires, Rui Bergantim, José E. Guimarães & M. Helena Vasconcelos. (2022) miRNAs mediated drug resistance in hematological malignancies. Seminars in Cancer Biology 83, pages 283-302.
Crossref
Crossref
Hui Wang, Wenchang Qian, Yingli Han & Pengxu Qian. (2022) Small noncoding RNAs play superior roles in maintaining hematopoietic stem cell homeostasis. Blood Science 4:3, pages 125-132.
Crossref
Crossref
Martina Monti, Susanna Lunardini, Igino Andrea Magli, Riccardo Campi, Giulia Primiceri, Francesco Berardinelli, Daniele Amparore, Daniela Terracciano, Giuseppe Lucarelli, Luigi Schips, Matteo Ferro & Michele Marchioni. (2022) Micro-RNAs Predict Response to Systemic Treatments in Metastatic Renal Cell Carcinoma Patients: Results from a Systematic Review of the Literature. Biomedicines 10:6, pages 1287.
Crossref
Crossref
Zsuzsanna Gaál. (2022) Implication of microRNAs in Carcinogenesis with Emphasis on Hematological Malignancies and Clinical Translation. International Journal of Molecular Sciences 23:10, pages 5838.
Crossref
Crossref
Abbas Navabi, Bahman Akbari, Mohammad Abdalsamadi & SeyedSaeid Naseri. (2022) The role of microRNAs in the development, progression and drug resistance of chronic myeloid leukemia and their potential clinical significance. Life Sciences 296, pages 120437.
Crossref
Crossref
Maria Fragiadaki. (2022) Lessons from microRNA biology: Top key cellular drivers of Autosomal Dominant Polycystic Kidney Disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1868:5, pages 166358.
Crossref
Crossref
Marjanu Hikmah Elias, Syarifah Faezah Syed Mohamad & Nazefah Abdul Hamid. (2022) A Systematic Review of Candidate miRNAs, Its Targeted Genes and Pathways in Chronic Myeloid Leukemia–An Integrated Bioinformatical Analysis. Frontiers in Oncology 12.
Crossref
Crossref
Maria Teresa Di Martino, Mariamena Arbitrio, Daniele Caracciolo, Alessia Cordua, Onofrio Cuomo, Katia Grillone, Caterina Riillo, Giulio Caridà, Francesca Scionti, Caterina Labanca, Caterina Romeo, Maria Anna Siciliano, Maria D'Apolito, Cristina Napoli, Martina Montesano, Valentina Farenza, Valentina Uppolo, Michele Tafuni, Federica Falcone, Giuseppe D'Aquino, Natale Daniele Calandruccio, Francesco Luciano, Licia Pensabene, Pierosandro Tagliaferri & Pierfrancesco Tassone. (2022) miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review. Molecular Therapy - Nucleic Acids 27, pages 1191-1224.
Crossref
Crossref
Xin Liu, Miao-Miao Cui, Hai-Zhen Zhu, Pei-Yi Fu, Guo-Chuan Wang & Ling Huang. (2022) MiR-199a-3p Overexpression Suppressed Cell Proliferation and Sensitized Chronic Myeloid Leukaemia Cells to Imatinib by Inhibiting mTOR Signalling. Acta Haematologica 145:5, pages 484-498.
Crossref
Crossref
Xiucai Xu, Shihong Yin, Yingli Ren, Chaojie Hu, Aimei Zhang & Ya Lin. (2021) Proteomics analysis reveals the correlation of programmed ROS‐autophagy loop and dysregulated G1/S checkpoint with imatinib resistance in chronic myeloid leukemia cells. PROTEOMICS 22:1-2, pages 2100094.
Crossref
Crossref
Jacek Kabzinski, Monika Maczynska & Ireneusz Majsterek. (2021) MicroRNA as a Novel Biomarker in the Diagnosis of Head and Neck Cancer. Biomolecules 11:6, pages 844.
Crossref
Crossref
Xifeng Zhang, Likun Yang & Guixia Xu. (2020) Silencing of long noncoding RNA TUG1 inhibits viability and promotes apoptosis of acute myeloid leukemia cells by targeting microRNA-221-3p/KIT axis. Clinical Hemorheology and Microcirculation 76:3, pages 425-437.
Crossref
Crossref
Ajaz A. Bhat, Salma N. Younes, Syed Shadab Raza, Lubna Zarif, Sabah Nisar, Ikhlak Ahmed, Rashid Mir, Sachin Kumar, Surender K. Sharawat, Sheema Hashem, Imadeldin Elfaki, Michal Kulinski, Shilpa Kuttikrishnan, Kirti S. Prabhu, Abdul Q. Khan, Santosh K. Yadav, Wael El-Rifai, Mohammad A. Zargar, Hatem Zayed, Mohammad Haris & Shahab Uddin. (2020) Role of non-coding RNA networks in leukemia progression, metastasis and drug resistance. Molecular Cancer 19:1.
Crossref
Crossref
Sarah B. Withers, Toni Dewhurst, Chloe Hammond & Caroline H. Topham. (2020) MiRNAs as Novel Adipokines: Obesity-Related Circulating MiRNAs Influence Chemosensitivity in Cancer Patients. Non-Coding RNA 6:1, pages 5.
Crossref
Crossref
Yingli Ren, Shihong Yin, Ya Lin & Xiucai Xu. (2019) Insulin‑like growth factor‑binding proteins play a significant role in the molecular response to imatinib in chronic myeloid leukemia patients. Experimental and Therapeutic Medicine.
Crossref
Crossref
Olga Yu. Olisova, D. R Amshinskaya & E. M Anpilogova. (2019) TO THE QUESTION OF DIFFERENTIAL DIAGNOSIS OF T CELL SKIN LYMPHOMAS. Russian Journal of Skin and Venereal Diseases 22:3-4, pages 68-72.
Crossref
Crossref